Structure-based virtual screening, molecular dynamics simulation and MM-PBSA toward identifying the inhibitors for two-component regulatory system protein NarL of Mycobacterium Tuberculosis.
The nitrate/nitrite response regulatory protein NarL belongs to the two-component regulatory system of Mycobacterium tuberculosis (MTB), plays a crucial role in anaerobic survival of mycobacteria in host. The absence of this protein in humans, makes it an attractive drug target for MTB treatment. However, the specific drug molecules targeting NarL are yet to be identified. In this study, we identified the promising drug candidates using structure based virtual screening of compounds from chemical libraries (ChEMBL and ZINC), followed by the extensive physicochemical properties analyses and molecular dynamics (MD) simulation. As the initial results, we obtained 4,754 bioactive compounds from ChEMBL having anti-tuberculosis activity which is finally narrowed down to the best 10 hits. A similar approach was applied to search for structurally similar compounds from ZINC data, corresponding to the top hits obtained from ChEMBL. Our collective results show that two compounds, ChEMBL509609 (Gscore - 5.054 kcal/mol, Xscore - 6.47 kcal/mol) and ZINC01843143 (Gscore - 5.114 kcal/mol, Xscore - 6.46 kcal/mol) having the best docking score and ADMET profile. The structural stability and dynamics of lead molecules at active site of NarL were examined using MD simulation and the binding free energies were estimated with MM-PBSA. Essential dynamics and MM-PBSA demonstrated that NarL-ChEMBL509609 complex remains the most stable during simulation of 100 ns with the higher binding free energy which may be a suitable candidate for further experimental analysis. Abbreviations ADME Absorption, Distribution, Metabolism, And Excretion BCG Bacillus Calmette-Guerin CNS Central nervous system DOTS Directly observed treatment, short course ED Essential dynamics HIV Human immunodeficiency virus HK Histidine kinase HOA Human oral absorption HTVS High throughput virtual screening IRRI Irritation MD Molecular dynamics MDR Multidrug resistant MTB Mycobacterium tuberculosis MUT Mutagenicity MW Molecular weight PHOA Percentage of human oral absorption REP Reproductive development Rg Radius of gyration RMSD Root mean square deviation RMSF Root mean square fluctuation RO5 Lipinski's rule of five RR Response regulator SP Standard precision SPG Standard precision glide TB Tuberculosis TCS Two-component regulatory system TDR Totally drug-resistant TUMO Tumorigenicity WHO World health organization XDR Extensively drug-resistant XP Extra precision Communicated by Ramaswamy H. Sarma.